<sup>161</sup> Tb draws an increasing interest in nuclear medicine for therapeutic applications. More than 99% of the emitted gamma and X-rays of <sup>161</sup> Tb have an energy below 100 keV. Consequently, precise activity measurement of <sup>161</sup> Tb becomes inaccurate with radionuclide dose calibrators when using inappropriate containers or calibration factors to account for the attenuation of this low energy radiation. To evaluate the ionization chamber response, the sample activity must be well known. This can be performed using standards traceable to the Système International de Référence, which is briefly described as well as the method to standardize the radionuclides. In this study, the resp...
This study presents current status of performance of radiopharmaceutical activity measurements using...
155Tb [t1/2 = 5.32 d, Eγ = 87 keV (32%); 105 keV (25%) (IAEA, 2021)] is a novel promising radionucli...
An energy response calibration of Landsverk L-65, L-81, and L-83 pocket chambers was carried out usi...
Background 161Tb draws an increasing interest in nuclear medicine for therapeutic applications. Mor...
<sup>161</sup> Tb draws an increasing interest in nuclear medicine for therapeutic appli...
The radiolanthanide <sup>161</sup> Tb is being studied as an alternative to <sup>1...
International audienceDue to their stability and reproducibility, re-entrant pressurized ionization ...
BackgroundPersonalized molecular radiotherapy based on theragnostics requires accurate quantificatio...
OBJECTIVE: The activity of injected radiopharmaceuticals in nuclear medicine, including beta-emitter...
<sup>161</sup> Tb, which emits low-energy β <sup>-</sup> - and γ-particles i...
Purpose: Reliable quantification of radioactivity in nuclear medicine is becoming increasingly impor...
<sup>161</sup> Tb, which emits low-energy β <sup>-</sup> - and γ-particles i...
Nuclear medicine is a scientific branch that makes use of radioactive nuclei to diagnose and treat c...
A portable instrument was developed at the Institute of Radiation Physics (IRA) for on-site radionuc...
International audienceThe present paper addresses the calibration of well-type ionization chambers (...
This study presents current status of performance of radiopharmaceutical activity measurements using...
155Tb [t1/2 = 5.32 d, Eγ = 87 keV (32%); 105 keV (25%) (IAEA, 2021)] is a novel promising radionucli...
An energy response calibration of Landsverk L-65, L-81, and L-83 pocket chambers was carried out usi...
Background 161Tb draws an increasing interest in nuclear medicine for therapeutic applications. Mor...
<sup>161</sup> Tb draws an increasing interest in nuclear medicine for therapeutic appli...
The radiolanthanide <sup>161</sup> Tb is being studied as an alternative to <sup>1...
International audienceDue to their stability and reproducibility, re-entrant pressurized ionization ...
BackgroundPersonalized molecular radiotherapy based on theragnostics requires accurate quantificatio...
OBJECTIVE: The activity of injected radiopharmaceuticals in nuclear medicine, including beta-emitter...
<sup>161</sup> Tb, which emits low-energy β <sup>-</sup> - and γ-particles i...
Purpose: Reliable quantification of radioactivity in nuclear medicine is becoming increasingly impor...
<sup>161</sup> Tb, which emits low-energy β <sup>-</sup> - and γ-particles i...
Nuclear medicine is a scientific branch that makes use of radioactive nuclei to diagnose and treat c...
A portable instrument was developed at the Institute of Radiation Physics (IRA) for on-site radionuc...
International audienceThe present paper addresses the calibration of well-type ionization chambers (...
This study presents current status of performance of radiopharmaceutical activity measurements using...
155Tb [t1/2 = 5.32 d, Eγ = 87 keV (32%); 105 keV (25%) (IAEA, 2021)] is a novel promising radionucli...
An energy response calibration of Landsverk L-65, L-81, and L-83 pocket chambers was carried out usi...